SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-308415
Filing Date
2022-12-19
Accepted
2022-12-19 17:01:00
Documents
18
Period of Report
2022-12-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d428971d8k.htm   iXBRL 8-K 66615
2 EX-10.1 d428971dex101.htm EX-10.1 127338
3 EX-10.2 d428971dex102.htm EX-10.2 66384
4 EX-10.3 d428971dex103.htm EX-10.3 55977
5 EX-10.4 d428971dex104.htm EX-10.4 47687
  Complete submission text file 0001193125-22-308415.txt   582031

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA inti-20221213.xsd EX-101.SCH 4985
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inti-20221213_cal.xml EX-101.CAL 682
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inti-20221213_def.xml EX-101.DEF 11558
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE inti-20221213_lab.xml EX-101.LAB 14547
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inti-20221213_pre.xml EX-101.PRE 11777
12 EXTRACTED XBRL INSTANCE DOCUMENT d428971d8k_htm.xml XML 2768
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13467 | Film No.: 221471879
SIC: 2834 Pharmaceutical Preparations